Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
16.75
-0.19 (-1.12%)
Nov 21, 2024, 11:44 AM EST - Market open
Cartesian Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Market Capitalization | 426 | 107 | - | - |
Enterprise Value | 226 | 123 | - | - |
Last Close Price | 16.94 | 20.68 | - | - |
PS Ratio | 4.33 | 4.11 | - | - |
PB Ratio | 512.19 | -0.77 | - | - |
EV/Sales Ratio | 4.71 | 4.75 | - | - |
Debt / Equity Ratio | 19.48 | -0.08 | 0.40 | 0.18 |
Debt / EBITDA Ratio | - | - | 2.01 | - |
Asset Turnover | 0.21 | 0.11 | 1.26 | - |
Quick Ratio | 10.51 | 1.26 | 5.76 | 6.38 |
Current Ratio | 10.70 | 1.33 | 5.91 | 6.42 |
Return on Equity (ROE) | -7029.26% | - | 70.21% | - |
Return on Assets (ROA) | -10.95% | -19.75% | 10.35% | - |
Return on Capital (ROIC) | -224.77% | -3022.09% | 12.98% | - |
Earnings Yield | -65.59% | -205.34% | - | - |
FCF Yield | -11.24% | -48.01% | - | - |
Buyback Yield / Dilution | -6.33% | -27.59% | - |
Total Shareholder Return | -6.33% | -27.59% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.